combination of cognitive behavioral therapy and medication in treatment of schizophrenia
Not Applicable
- Conditions
- schizophrenia.Schizophrenia
- Registration Number
- IRCT2016110627691N2
- Lead Sponsor
- Tehran University of Medical Science ?Deputy of resaerch
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
patients with schizophrenia disorder according to DSM- IV -TR classificationand interview ; age between 20 to 50 ? at least 8 classes education; Patients will enrolled in the study only after obtaining informed consent; CBT will be the only psychosocial intervention which will be provided to these patients. Exclusion criteria:, with at least 8 classes education;Patients with any history of substance abuse ;.patients with any history of neurological or medical disorders
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Positive symptoms. Timepoint: at the first and after termination of cognitive behavioral therapy sessions and 12 weeks after the last sessions. Method of measurement: positive and negative syndrome scale.;Negative symptoms. Timepoint: at the first and after termination of cognitive behavioral therapy sessions and 12 weeks after the last sessions. Method of measurement: positive and negative syndrome scale.
- Secondary Outcome Measures
Name Time Method Quality of life. Timepoint: at the first and after termination of cognitive behavioral therapy sessions and 12 weeks after the last sessions. Method of measurement: World Health organizatin-Quality of life.;Insight. Timepoint: at the first and after termination of cognitive behavioral therapy sessions and 12 weeks after the last sessions. Method of measurement: Insight scale.;Global functional patients. Timepoint: at the first and after termination of cognitive behavioral therapy sessions and 12 weeks after the last sessions. Method of measurement: Global Assessment of functioning scale.